Trials / Completed
CompletedNCT01168492
Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Université de Montréal · Academic / Other
- Sex
- All
- Age
- 10 Years – 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether ketamine, midazolam, and meperidine are more effective than midazolam and meperidine alone for procedural sedation and analgesia in pediatric digestive endoscopy. Secondary outcomes are the incidence of cardiorespiratory side effects and the necessity of rescue doses.
Detailed description
90 patients will be included. The sedation will include 0.1mg/kg, max 5mg iv of midazolam, 1mg/kg, max 50mg iv of meperidine, and placebo (0.9%NaCl) or ketamine 0.5mg/kg iv. Rescue doses will be given as usual, using meperidine and or midazolam 50% of the initial dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ketamine | 0.5mg/kg ketamine iv |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2010-07-23
- Last updated
- 2014-12-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01168492. Inclusion in this directory is not an endorsement.